We are here for people affected by multiple sclerosis!
MS-UK is a national charity formed in 1993. Around 130,000 people in the UK or one in every 500, with about 130 people diagnosed every week on average.
In the news
New trial tests clemastine and metformin for MS
New clinical trial will test diabetes drug and antihistamine for MSPublished 26 April 2022 A new clinical trial is taking place which will test to see if taking diabetes drug metformin, and antihistamine drug clemastine, could be used to help repair myelin in people with multiple sclerosis (MS). LaboratoryChildhood abuse increases MS risk
Childhood abuse increases MS riskPublished 07 April 2022 Suffering trauma in childhood may increase the risk of developing multiple sclerosis (MS) in women in later life, according to a new study. Experts know that abuse and neglect in childhood are associated with a higher risk of poor mental and physicalSmell test might predict DMT affectiveness
Smell test might help predict DMT effectivenessPublished 04 April 2022 A smell test could be used to tell whether treatments for multiple sclerosis (MS) are working or not, a new study suggests. Researchers in Austria teste whether measuring olfactory threshold (OT) could be a way to detect whether a personThe course that helped with MS depression
The course that helped with MS depressionPublished 29 march 2022 A new report from Australia has found an eight-week online course lowered levels of depression and improved life quality in people with multiple sclerosis. Researchers at the University of Sydney created an eight-week course with five interactive sessions. These were
Hormone therapy, MS and menopause
Hormone therapy, MS and menopausePublished 18 March 2022 What role in a woman’s hormones, and in particular, the hormone changes during the menopause, play in the progression of multiple sclerosis (MS)? At the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Forum 2022, Dr Burcu Zeydan, assistant professor
Bladder and Bowel Community issue plea
Bladder and Bowel Community issue pleaPublished 15 March 2022 People living with multiple sclerosis (MS) can often have issues with their bladder and bowel function, so much so that even leaving the house can cause extreme anxiety. In March 2021, the Bladder and Bowel Community announced the launch of theNew report highlights lack of MS nurses
New report highlights lack of MS nursesPublished 15 March 2022 Eighty percent of people with multiple sclerosis (MS) are missing out on the essential care and support they need because they are looked after by specialist nurses with too many people on their books according to a new report. TheThis diet may lower the risk of multiple sclerosis
This diet may lower the risk of multiple sclerosisPublished 22 February 2022 A new study from Iran suggests that eating a diet high in green leafy vegetables, nuts, beans and berries may lower the risk of getting multiple sclerosis (MS). The research team looked at whether the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietNew drug for MS approved in Scotland
New drug for MS approved in ScotlandPublished 22 February 2022 Vumerity (diroximel fumarate) has been approved for use on the NHS for people with multiple sclerosis (MS). Vumerity is taken orally as a tablet twice a day. It is as effective as Tecfidera (dimethyl fumarate) but doesn’t cause as many stomach problems.
MS may raise risk of long Covid
MS may raise the risk of long CovidPublished 22 February 2022 A new study has found that almost a third of people with multiple sclerosis (MS) who get Covid-19 have symptoms lasting for at least a month. Researchers reviewed more than 550 cases of people infected with Covid-19 who have MS, none of whomCould eating meat be linked to multiple sclerosis?
Could eating meat be linked to multiple sclerosis?Published 22 February 2022 Those who eat meat may have a higher risk of developing multiple sclerosis (MS) than those who don’t, a new study has concluded. Researchers at the University of Connecticut looked at the diet, gut bacteria, immune systems and blood of 25
Is this why the Epstein-Barr virus triggers MS?
Is this why the Epstein-Barr virus causes MS?Published 22 February 2022 A new study may have discovered the reason the Epstein-Barr virus (EBV) increases the risk of multiple sclerosis (MS). Structural similarities between a brain protein called GlialCam and a protein in EBV might cause B-cells, immune cells that are involved in the development
New drug approved on NHS for multiple sclerosis
New drug approved on NHS for multiple sclerosisPublished 21 February 2022 Ponvory (ponesimod) has been approved for use on the NHS in England and Wales by the National Institute for Health and Care Excellence (NICE) for active relapsing remitting multiple sclerosis (MS). This decision reverses NICE’s earlier rejection of Ponvory which came lastVirus may cause virtually all cases of MS
Virus may cause virtually all cases of MS Virtually every case of multiple sclerosis (MS) is preceded by an infection with the Epstein-Barr virus (EBV), a new study has found. Known as glandular fever, the EBV has long been a suspected trigger for MS. The virus is a type of herpes and is spread
Spinal fluid toxin levels high in MS patients
Spinal fluid toxin levels high in MS patientsPublished 21 February 2022 A new study has found high levels of three toxic metabolites produced by gut bacteria in the cerebrospinal fluid and plasma samples of multiple sclerosis (MS) patients. The findings, published in the journal Brain, will help further scientists' understanding of howTwo diets that benefit people with MS
Two diets that benefit people with MSPublished 21 February 2022 A secondary analysis of a study published last year has found that the Wahls diet (paleolithic) or Swank diet (low-saturated-fat) are associated with better cognition, reduced fatigue, and improved quality of life in people with relapsing remitting multiple sclerosis (MS). The Wahls and Swank dietsEarlier MS diagnosis may be possible
Earlier MS diagnosis may be possiblePublished 10 January 2022 A new machine learning algorithm devised by scientists at the University of California San Francisco could help doctors diagnose multiple sclerosis (MS) earlier, by analysing healthcare records and identifying symptoms earlier, a study has found. There is quite a bit of research whichQuitting smoking slows MS progression
Quitting smoking slows MS progressionPublished 21 October 2021 Quitting smoking may slow disease progression in people with multiple sclerosis (MS) a new large real-world study has found. Researchers found that in people who had quit smoking, disease progression was slowed to a similar rate of progression seen in people whoThese foods may lessen MS symptoms and boost gut health
These foods may lessen MS symptoms and boost gut healthPublished 20 July 2021 A new study found eating certain foods to alter gut bacteria may lessen symptoms of multiple sclerosis (MS). Researchers had observed that people with MS lack the strain of bacteria that breaks down isoflavones, a nutrient commonlyDiet benefits people with multiple sclerosis
Diet benefits people with multiple sclerosisPublished 22 June 2021 A diet designed to improve the health of the brain may benefit people with multiple sclerosis (MS), a new study has found. There are many diets for MS. Researchers from the Ichahn School of Medicine at Mount Sinai in New YorkDrug rejected for NHS use in England and Wales for multiple sclerosis
Drug rejected for NHS use in England and Wales for multiple sclerosis The National Institute for Health and Care Excellence (NICE) has announced it does not recommend Zeposia (ozanimod) for multiple sclerosis (MS) treatment on the NHS in England and Wales. The drug was approved by the Scottish Medicines ConsortiumMS and memory problems – a cause identified
MS and memory problems – a cause identifiedPublished 06 May 2021 A new study has found missing out on sleep may worsen the memory of people with clinically isolated syndrome or relapsing remitting multiple sclerosis (MS). Researchers also found a link between sleep deprivation and worse cognitive efficiency, although they30 minutes of sun lowers MS risk in kids
30 minutes of sun lowers MS risk in kidsPublished 03 March 2021 Spending more time in the sun during summer is strongly protective for very early-onset multiple sclerosis (MS), as is residing in a sunnier location, according to a new study which was presented at the Americas Committee for Treatment38 disabled badge holders to one council-owned parking space
38 disabled badge holders to one council-owned parking spacePublished 14 September 2020 Disabled badge holders may be dismayed to hear there are 38 Blue Badge holders to one council-owned parking space according to new data obtained through Freedom of Information requests by Confused.com. Since the scheme was updated in England,
MS-UK win Campaign of the Year
MS-UK win Campaign of the YearPublished 14 June 2021 MS-UK are celebrating after scooping Campaign of the Year at the Institute of Fundraising East Anglia regional awards for their My MS Marathon campaign. More than 20 charities across the region submitted entries, and My MS Marathon stood out to the
MS doesn’t increase breast cancer death in women
MS doesn't increase breast cancer death in womenPublished 03 June 2021 Women with MS do not have higher risk of dying from breast cancer A new study from Canada has found that women with multiple sclerosis (MS) and breast cancer do not have a higher risk of dying than those without the neurological condition.Drug rejected for NHS use in England and Wales for multiple sclerosis
Drug rejected for NHS use in England and Wales for multiple sclerosisPublished 13 October 2021 The National Institute for Health and Care Excellence (NICE) has announced it does not recommend Zeposia (ozanimod) for multiple sclerosis (MS) treatment on the NHS in England and Wales. The drug was approved by the Scottish Medicines Consortium inMultiple sclerosis DMTs that target B-cells may lessen Covid-19 antibodies
Multiple sclerosis DMTs that target B-cells may lessen Covid-19 antibodiesPublished 17 May 2021 Therapies for people with multiple sclerosis (MS) that deplete B-cells affect antibodies for Covid-19, a new study has found. Most disease-modifying therapies (DMTs) for MS limit immune responses to suppress the system’s attacks on the myelin sheath that protects1.4 million cannabis users in UK
1.4 million cannabis users in the UKPublished 15 January 2022 More than a million people are using cannabis illegally to self-medicate in the UK, according to a new YouGov poll. The survey found that there are 1.4 million users, half of which take the drug every day. The total spend
How you can donate
MS-UK is here for anyone affected by multiple sclerosis (MS), to empower them to live healthier and happier lives by improving the understanding of MS and providing support where it is needed most.
We put people living with MS at the heart of our work and your generosity ensures we can continue to provide high quality, professional services such as our helpline, counselling service and our magazine.
Your donation will make sure we are always here to support people to have choice, control and independence. Thank you for helping us be there for people affected by MS, today and in the future.
